from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0440/groEL2

LFCtreatmentdescriptionclass of inhibitor

0.921

Amikacinug/mL Amikacintranslation

-1.729

Cap5-10ug/mL Capreomycintranslation

-1.959

Rox10-50 ug/mL Roxithromycintranslation

1.378

SM2-5 ug/mL Streptomycintranslation

-1.894

Tet5-10 ug/mL Tetracyclinetranslation

-1.326

Rif0.2-5ug/mL Rifampicintranscription

-1.454

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.871

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.480

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.056

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.025

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.264

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.791

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.160

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.964

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.506

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.185

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.659

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.917

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.847

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.232

KCN5-20 ug/mL Potassium cyaniderespiration

-0.317

NaN30.2-2 mM Sodium aziderespiration

-0.124

Nigericin50 uM Nigericinrespiration

-0.429

TRC10-150 ug/mL Triclosanrespiration

-0.828

TRZ10-25 ug/mL Thioridazinerespiration

-0.405

Valinomycin0.5-10 uM Valinomycinrespiration

0.561

ZnSO42 mM ZnSO4respiration

0.620

menadione6-10 ug/mL Menadionerespiration

0.421

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.625

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.546

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.427

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.233

NRP_1Non-replicating persistence stage 1dosRassociated

0.406

Amp0.2mg/mL AmpicillincellWall

0.432

Cephalexin20-100 ug/mL CephalexincellWall

0.613

Cerulenin0.32-5 ug/mL CerulenincellWall

0.578

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.144

EMB10-20 ug/mL EthambutolcellWall

0.048

Eta12-40 ug/mL EthionamidecellWall

0.358

INH0.2-0.4 ug/mL IsoniazidcellWall

0.062

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.013

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.070

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.988

BZA0.12 mg/mL BenzamidearomaticAmides

1.071

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.352

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.585

H2O24 mM hydrogen peroxideDNAdamaging

0.202

Levo10 ug/mL LevofloxacinDNAdamaging

0.763

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.190

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.473

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.726

UVUV-irradiationDNAdamaging

0.561

ARP41-4 ug/mL Antitubercular compound ARP4?

0.667

Antimycin12.5-50 ug/mL Antimycin A?

0.549

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.492

PA_110-50 ug/mL Antitubercular compound PA-1?

0.327

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.433

PA8240.2-2 ug/mL PA-824?

-0.379

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.218

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.318

Verapamil50 uM Verapamil?

1.094

mercaptoethanol2 mM 2-Mercaptoethanol?

1.165

methoxatin10-20 ug/mL Methoxatin?